[Progress in viral hepatitis].
D000208:Acute Disease; D000818:Animals; D002353:Carrier State / Q000276:immunology; D003364:Costa Rica; D006506:Hepatitis A / Q000276:immunology; D006509:Hepatitis B / Q000517:prevention & control; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D006515:Hepatitis B virus / Q000276:immunology; D006526:Hepatitis C / Q000453:epidemiology / Q000276:immunology; D006525:Hepatitis, Viral, Human / Q000276:immunology*; D006801:Humans; D007194:India; D002679:Pan troglodytes; D012537:Scandinavian and Nordic Countries; D014481:United States; D014765:Viral Vaccines / Q000627:therapeutic use
D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D014765:Viral Vaccines
Progrès concernant les hépatites virales.